A randomized comparison of intravenously administered granisetron versus chlorpromazine plus dexamethasone in the prevention of ifosfamide-induced emesis in children

This publication has 12 references indexed in Scilit:

• The Efficacy and Safety of Granisetron in Pediatric Cancer Patients Who Had Failed Standard Antiemetic Therapy During Anticancer Chemotherapy
  Journal of Pediatric Hematology/Oncology, 1994
• A dose-finding study of granisetron, a novel antiemetic, in patients receiving high-dose cisplatin
  Supportive Care in Cancer, 1994
• The efficacy and safety of ondansetron in the prophylaxis of cancer-chemotherapy induced nausea and vomiting in children
  Clinical Oncology, 1993
• Prevention of emesis by ics 205-930 in children receiving cytotoxic chemotherapy
  European Journal Of Cancer, 1993
• The control of acute cisplatin-induced emesis – a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone
  British Journal of Cancer, 1993
• Ondansetron as Prophylaxis for Chemotherapy and Radiotherapy-Induced Emesis in Children
  Oncology, 1992
• Efficacy and safety of granisetron in the prevention of chemotherapy-induced emesis in paediatric patients
  European Journal of Cancer and Clinical Oncology, 1991
• 5-HT3 antagonist ondansetron--an effective outpatient antiemetic in cancer treatment.
  Archives of Disease in Childhood, 1990
• Antiemetics in children receiving cancer chemotherapy: a double-blind prospective randomized study comparing metoclopramide with chlorpromazine.
  Journal of Clinical Oncology, 1986
• Methylprednisolone for chemotherapy-induced emesis: A double-blind randomized trial in children
  The Journal of Pediatrics, 1986